In conclusion, the results of this meta-analysis add to the evidence that metformin may be particularly useful in women with GDM at high risk for neonatal hypoglycemia, women who want to limit maternal and fetal weight gain, or women with an inability to afford or use insulin safely. The gene discussed is INS; the disease is Hypoglycemia.